BACKGROUND: Patterns of heroin and cocaine use vary and may be associated with unique risk factors for bloodborne infections. METHODS: Latent class analysis identified sub-populations of 552 heroin and cocaine users in Baltimore, Maryland. Using latent class regression, these classes were analyzed for associations with demographic characteristics, risky behaviors, Hepatitis C, and HIV. RESULTS: Three classes were found: Crack/Nasal-Heroin users (43.5%), Polysubstance users (34.8%), and Heroin Injectors (21.8%). Compared to Polysubstance users, Crack/Nasal-Heroin users were almost 7 times more likely to identify as Black (OR=6.97, 95% CI=4.35-11.2). Sharing needles was over 2.5 times more likely among Polysubstance users than among Heroin Injectors (OR=2.66, 95% CI=1.49-4.75). Crack/Nasal-Heroin users were 2.5 times more likely than Polysubstance users to exchange drugs for sex (OR=2.50, 95% CI=1.22-5.13). Crack/Nasal-Heroin users were less likely than Heroin Injectors to have Hepatitis C (OR=0.10, 95% CI=0.06-0.18), but no significant differences were found for HIV. CONCLUSIONS: Subpopulations of cocaine and heroin users differed in demographic classifications, HIV-risk behaviors, and Hepatitis C infection. All subpopulations included substantial numbers of HIV-positive individuals. Findings provide further evidence that non-injection drug users face significant infectious disease risk.
BACKGROUND: Patterns of heroin and cocaine use vary and may be associated with unique risk factors for bloodborne infections. METHODS: Latent class analysis identified sub-populations of 552 heroin and cocaine users in Baltimore, Maryland. Using latent class regression, these classes were analyzed for associations with demographic characteristics, risky behaviors, Hepatitis C, and HIV. RESULTS: Three classes were found: Crack/Nasal-Heroin users (43.5%), Polysubstance users (34.8%), and Heroin Injectors (21.8%). Compared to Polysubstance users, Crack/Nasal-Heroin users were almost 7 times more likely to identify as Black (OR=6.97, 95% CI=4.35-11.2). Sharing needles was over 2.5 times more likely among Polysubstance users than among Heroin Injectors (OR=2.66, 95% CI=1.49-4.75). Crack/Nasal-Heroin users were 2.5 times more likely than Polysubstance users to exchange drugs for sex (OR=2.50, 95% CI=1.22-5.13). Crack/Nasal-Heroin users were less likely than Heroin Injectors to have Hepatitis C (OR=0.10, 95% CI=0.06-0.18), but no significant differences were found for HIV. CONCLUSIONS: Subpopulations of cocaine and heroin users differed in demographic classifications, HIV-risk behaviors, and Hepatitis C infection. All subpopulations included substantial numbers of HIV-positive individuals. Findings provide further evidence that non-injection drug users face significant infectious disease risk.
Authors: Samuel M Jenness; Paul Kobrak; Travis Wendel; Alan Neaigus; Christopher S Murrill; Holly Hagan Journal: J Urban Health Date: 2011-04 Impact factor: 3.671
Authors: Ashwin A Patkar; Allan Lundy; Frank T Leone; Stephen P Weinstein; Edward Gottheil; Michael Steinberg Journal: Subst Abus Date: 2002-06 Impact factor: 3.716
Authors: B Jacka; B C Bray; T L Applegate; B D L Marshall; V D Lima; K Hayashi; K DeBeck; J Raghwani; P R Harrigan; M Krajden; J S G Montaner; J Grebely Journal: J Viral Hepat Date: 2017-09-04 Impact factor: 3.728
Authors: Nicole Ennis Whitehead; Rebecca C Trenz; Larry Keen; Jonathan Rose; William W Latimer Journal: J Ethn Subst Abuse Date: 2014 Impact factor: 1.507
Authors: P Truman Harrell; Brent Edward E Mancha; Silvia S Martins; Pia M Mauro; Julie H Kuo; Michael Scherer; Karen I Bolla; William W Latimer Journal: Am J Addict Date: 2014-03-15
Authors: Philip A Chan; Jennifer Rose; Justine Maher; Stacey Benben; Kristen Pfeiffer; Alexi Almonte; Joanna Poceta; Catherine E Oldenburg; Sharon Parker; Brandon Dl Marshall; Mickey Lally; Kenneth Mayer; Leandro Mena; Rupa Patel; Amy S Nunn Journal: AIDS Patient Care STDS Date: 2015-09-21 Impact factor: 5.078
Authors: Paul T Harrell; Syeda Mahrukh Hussnain Naqvi; Andrew D Plunk; Ming Ji; Silvia S Martins Journal: Am J Drug Alcohol Abuse Date: 2016-09-26 Impact factor: 3.829
Authors: Philip A Chan; Joseph W Hogan; Austin Huang; Allison DeLong; Marco Salemi; Kenneth H Mayer; Rami Kantor Journal: J Acquir Immune Defic Syndr Date: 2015-12-01 Impact factor: 3.731